Raymond James Reaffirms Outperform Rating for Fulgent Genetics (NASDAQ:FLGT)
Fulgent Genetics (NASDAQ:FLGT – Get Free Report)‘s stock had its “outperform” rating restated by Raymond James in a note issued to investors on Monday, MarketBeat.com reports. They currently have a $25.00 target price on the stock, up from their prior target price of $24.00. Raymond James’ price objective points to a potential upside of 32.84% […]
Fulgent Genetics (NASDAQ:FLGT – Get Free Report)‘s stock had its “outperform” rating restated by Raymond James in a note issued to investors on Monday, MarketBeat.com reports. They currently have a $25.00 target price on the stock, up from their prior target price of $24.00. Raymond James’ price objective points to a potential upside of 32.84% […]
